vanilmandelic acid has been researched along with Trigeminal Neuralgia in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
Excerpt | Relevance | Reference |
---|---|---|
"Substance P was significantly elevated (P < 0." | 1.30 | Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. ( Blaes, F; Fischer, C; Grauer, M; Hamann, G; Hoffmann, KH; Isenberg, E; Schimrigk, K; Strittmatter, M, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strittmatter, M | 1 |
Grauer, M | 1 |
Isenberg, E | 1 |
Hamann, G | 1 |
Fischer, C | 1 |
Hoffmann, KH | 1 |
Blaes, F | 1 |
Schimrigk, K | 1 |
1 other study available for vanilmandelic acid and Trigeminal Neuralgia
Article | Year |
---|---|
Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia.
Topics: Biogenic Monoamines; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1997 |